Apriori Bio

Apriori Bio, a Flagship Pioneering company, is dedicated to innovating in vaccine and antibody technology to protect humanity against viral threats. The company's core mission is to develop variant-resilient vaccines and provide actionable real-time insights to prepare for future viral outbreaks. Apriori Bio leverages a unique technology platform to learn from current viruses and enhance global viral protection. Their market focus includes public health sectors and organizations involved in pandemic preparedness and response.

Notable affiliations include its backing by Flagship Pioneering, a prominent venture capital firm known for fostering groundbreaking biotech companies. Apriori Bio has been featured on Fast Company’s Innovation By Design Pandemic Action List, highlighting its impactful contributions to pandemic preparedness. The company's achievements in developing advanced vaccine technologies and real-time viral insights have positioned it as a key player in the fight against global viral threats, significantly impacting public health strategies worldwide.